Home/Smart Money/Merck & Co., Inc.
§ 13F · FUND PROFILE

Merck & Co., Inc..

AUM · $526M (13F)Positions · 13Turnover · n/a · Q2Filed · Aug 7, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
+$26M deployed
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS

The book · Q2 2026

FILED AUG 7, 2026
#TickerNameShares$ value% portΔ Q2
1PSNLPERSONALIS INC14.04M$188M35.8%±0%
2MRNAMODERNA INC2.31M$162M30.7%±0%
3KYMRKYMERA THERAPEUTICS INC772K$89M16.8%±0%
4AKTSAKTIS ONCOLOGY INC953K$31M5.8%±0%
5EIKNEIKON THERAPEUTICS INC1.67M$22M4.1%±0%
6TRDAENTRADA THERAPEUTICS INC1.74M$13M2.4%NEW
7STROSUTRO BIOPHARMA INC272K$9M1.7%NEW
8ALECALECTOR INC3.55M$7M1.4%±0%
9EVAXEVAXION BIOTECH A/S1.21M$4M0.7%NEW
10VRDNVIRIDIAN THERAPEUTICS INC93K$2M0.3%±0%
§ 02 · SECTOR ALLOCATION

Where the money is

Sector data pending
§ 03 · THE MERCK SIGNAL

AC read

Merck & Co., Inc. is a Other fund managing $526 million in assets. The fund runs a focused portfolio of just 13 positions.

Read the full dossier →